These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of neurotransmitter regulators in functional gastrointestinal disorders based on symptom analysis. Luo QQ; Chen SL J Dig Dis; 2017 Apr; 18(4):203-206. PubMed ID: 28371414 [TBL] [Abstract][Full Text] [Related]
3. Serotonergic modulators in the treatment of irritable bowel syndrome: influence on psychiatric and gastrointestinal symptoms. Castle MZ; Silk DB; Libby GW Aliment Pharmacol Ther; 2003 Jun; 17(11):1425. PubMed ID: 12786637 [No Abstract] [Full Text] [Related]
4. Use of psychopharmacological agents for functional gastrointestinal disorders. Clouse RE; Lustman PJ Gut; 2005 Sep; 54(9):1332-41. PubMed ID: 16099800 [No Abstract] [Full Text] [Related]
5. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869 [TBL] [Abstract][Full Text] [Related]
6. Central nervous system approaches for treating functional disorders: how, when, and why? Clouse RE J Pediatr Gastroenterol Nutr; 2004 Jun; 39 Suppl 3():S763-5. PubMed ID: 15167380 [No Abstract] [Full Text] [Related]
7. Antidepressants for irritable bowel syndrome. Clouse RE Gut; 2003 Apr; 52(4):598-9. PubMed ID: 12631677 [No Abstract] [Full Text] [Related]
8. Pharmacotherapy of altered brain-gut interactions in functional gastrointestinal disorders. Clouse RE J Pediatr Gastroenterol Nutr; 1997; 25 Suppl 1():S18-9. PubMed ID: 9285856 [No Abstract] [Full Text] [Related]
9. Antidepressant use in gastroenterology: Overcoming hurdles. Keszthelyi D Neurogastroenterol Motil; 2020 Oct; 32(10):e13982. PubMed ID: 32935408 [No Abstract] [Full Text] [Related]